JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 2. (A) CCS angina pectoris classification at baseline and after 3 mo of follow-up in 3 groups (control, standard therapy; DMR, laser treatment; VEGF, VGEF gene therapy). Changes were significantly different between the 3 groups (P < 0.001). (B) Change in CCS class in 3 individual groups. Change in VEGF gene therapy group was significantly different from that of other 2 groups (P < 0.05).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE